An update is provided of our ongoing sclerotherapy experience at Henry Ford Hospital, based on 47 patients who have undergone this procedure. One-month mortality rates for Child's classes C, B, and A were 50%, 22%, and 0%, respectively. Follow-up after one month revealed ten additional mortalities, but none were secondary to esophageal variceal hemorrhage. Strictures secondary to sclerotherapy were amenable to dilation. We advocate sclerotherapy as the treatment of choice for esophageal variceal hemorrhage.
Verbeck, Stephen R.; Zonca, Martin C.; and Wong, Dominic K. H.
"Injection Sclerotherapy of Bleeding Esophageal Varices: The Henry Ford Hospital Experience,"
Henry Ford Hospital Medical Journal
: Vol. 34
Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol34/iss2/13